Biotech Snap

A daily 5-min biotech briefing

Latest news

The race for the next obesity blockbuster intensifies as Novo, Pfizer and Skye share results

Joachim Eeckhout, +1

Sanofi wins in Gaucher disease & GSK abandons a pioneering RNA editing drug

Joachim Eeckhout, +1

AstraZeneca signs a massive $18B obesity deal & a bunch of pharmas clean their pipeline

Joachim Eeckhout, +1

Repertoire signs a $1.9B autoimmune disorders deal & Sanofi cleans its pipeline

Joachim Eeckhout, +1

A wave of hearing loss gene therapies & Boehringer advance a kidney drug into pivotal trial

Joachim Eeckhout, +1

Boehringer inks a €1.05B with Simcere & Roche shows what its weight-loss drug can do

Joachim Eeckhout, +1

Fortitude launches to combine ADCs with protein degraders & Sanofi takes a gamble with eczema

Joachim Eeckhout, +1

Corvus' stock explodes on eczema pill results & Corxel raises $287 million for its oral GLP-1

Joachim Eeckhout, +1

Pfizer signs a $530M vaccine deal & Novo drops another cell therapy

Joachim Eeckhout, +1

GSK buys a food allergy biotech for $2.2B & Exciva raises €51M to fight Alzheimer’s agitation symptoms

Joachim Eeckhout, +1

SpyGlass and Agomab plan an IPO & Genmab fails a Phase 3

Joachim Eeckhout, +1

Vor Bio changes its priorities & Novo Nordisk Foundation injects €736M in European biotech

Joachim Eeckhout, +1

1 2 3 4 5 6 7 8